Health
Sortilin may hold the key to developing more effective treatment for pancreatic cancer – News-Medical.Net
Pancreatic cancer has an extremely poor prognosis; it is the third most common cause of cancer deaths in the United States.
Reviewed by Emily Henderson, B.Sc.Aug 20 2020
Pancreatic cancer has an extremely poor prognosis; it is the third most common cause of cancer deaths in the United States. In a novel study published in TheAmerican Journal of Pathology, published by Elsevier, scientists report the discovery of an increased level of the neuroprotein sortilin in pancreatic cancer cells that may open up the way to developing more effective treatment.
There is currently no good therapy for pancreatic cancer. What we …
-
Noosa News24 hours agoWoman was watching keepers work when lion attacked, Darling Downs Zoo says
-
Noosa News22 hours agoWorking for someone else made it hard to care for my daughter. So I quit
-
Business9 hours agoFord CEO makes stunning prediction about artificial intelligence
-
General18 hours ago‘Potential’ hacker contacts Qantas over data breach